Cargando…
Inner ear cell therapy targeting hereditary deafness by activation of stem cell homing factors
Congenital deafness affects about 1 in 1000 children and more than half of them have a genetic background such as Connexin26 (CX26) gene mutation. Inner ear cell therapy for sensorineural hearing loss has been expected to be an effective therapy for hereditary deafness. Previously, we developed a no...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307216/ https://www.ncbi.nlm.nih.gov/pubmed/25674062 http://dx.doi.org/10.3389/fphar.2015.00002 |